Form 4: Arcellx's Chief Medical Officer, Christopher Heery, Executes Stock Option and Sells Shares
SEC Form 4 Filing
Christopher Heery, Chief Medical Officer of Arcellx, Inc., exercised stock options and sold shares of common stock on August 26, 2024, according to a Form 4 filing with the SEC.
Summary
- On August 26, 2024, Christopher Heery, the Chief Medical Officer of Arcellx, Inc., engaged in transactions involving the company's common stock.
- He exercised a stock option to acquire 21,684 shares at an exercise price of $15.
- Following the exercise, Heery sold 6,432 shares at a weighted average price of $70.6103 and 15,252 shares at a weighted average price of $71.342.
- These sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 22, 2023.
- After these transactions, Heery directly owns 9,278 shares of Arcellx common stock.
- He also holds options for 157,837 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock transactions by an executive under a pre-existing trading plan. There is no indication of positive or negative news about the company.
Industry Context
This filing is a routine disclosure of insider transactions and provides transparency to the market regarding the trading activities of company executives. It is common for executives to utilize 10b5-1 trading plans to manage their stock sales and avoid accusations of insider trading.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely to be minimal given the relatively small volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| 2022-02-03 | Equity Grant Date for stock options. |
| 2023-12-22 | Date of adoption of Rule 10b5-1 trading plan. |
| 2024-08-26 | Date of stock option exercise and stock sales. |
| 2032-02-03 | Expiration date of stock options. |
| 2024-08-28 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.